Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1724-6059
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects ; volume:27 ; number:6 ; day:4 ; month:4 ; year:2014 ; pages:659-666 ; date:12.2014
Journal of nephrology ; 27, Heft 6 (4.4.2014), 659-666, 12.2014
- Urheber
-
Chong, Edward
Kalia, Veena
Willsie, Sandra
Winkle, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40620-014-0080-1
- URN
-
urn:nbn:de:101:1-2019063011490765017254
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chong, Edward
- Kalia, Veena
- Willsie, Sandra
- Winkle, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Case report: Medical cannabis—warfarin drug-drug interaction
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Case report: Medical cannabis—warfarin drug-drug interaction
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Case report: Medical cannabis—warfarin drug-drug interaction
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions